Search results
Results from the WOW.Com Content Network
In June, Abbvie acquired TeneoOne and its lead compound TNB-383B. The compound is a BCMA-targeting immunotherapeutic for relapsed or refractory multiple myeloma. [30] In March 2022, AbbVie acquired Syndesi Therapeutics for up to $1 billion and its portfolio of novel modulators of the synaptic vesicle protein 2A and lead compound SDI-118.
Research funding is a term generally covering any funding for scientific research, in the areas of natural science, technology, and social science.Different methods can be used to disburse funding, but the term often connotes funding obtained through a competitive process, in which potential research projects are evaluated and only the most promising receive funding.
Spectrum Pharmaceuticals, Inc. is an American biopharmaceutical company located in Boston, MA.It develops and markets drugs for treatments in hematology and oncology.. After a deal valued at $248 million was announced in April 2023, [1] [2] Assertio Holdings announced that it had completed its acquisition of the Massachusetts-based company on July 31.
Grant management software is a program or application that helps non-profits administer the grant process. Some software is designed to help foundations (known as "grantmakers") to organize, prioritize, and process the grant applications they receive from charities (known as "grantseekers"), as well as simplify oversight of the grants they make.
The most common research grant mechanism is the R01. It is the oldest funding mechanism of the NIH. R01s are generally awarded for 3–5 years, and are used to support a "discrete, specified, circumscribed research project". R01s can be renewed by competitive application. The application cycle has 3 sets of application dates each year.
Zeltiq Aesthetics is a subsidiary of AbbVie based in Pleasanton, California that markets and licenses devices used for cryolipolysis procedures. The company was founded in 2005 and raised $75 million in funding before going public in 2011. It was acquired by Allergan in February 2017 for $2.48 billion.
BioMarin was founded in 1997 by Christopher Starr Ph.D. and Grant W. Denison Jr. with an investment of a $1.5 million from Glyko Biomedical and went public in 1999. [7] Seed investors were amongst others MPM Bioventures, Grosvenor Fund and Florian Schönharting. [8]
The Medicines Patent Pool (MPP) is a Unitaid-backed international organisation founded in July 2010, [1] based in Geneva, Switzerland.Its public health driven business model aims to lower the prices of HIV, tuberculosis and hepatitis C medicines and facilitate the development of better-adapted HIV treatments through voluntary licensing and patent pooling.